File: '\\swfile\EmailIn\20250113 054259 Attachment MedBright_AI_-_Chris_Cherry.docx'

MedBright AI Appointments Christopher Cherry as Interim CEO

Vancouver, British Columbia - January 13, 2025 - MedBright AI Investments Inc. (the "Company" or "MedBright AI") (CSE:MBAI, OTCQB:MBAIF, FSE:Y30) is pleased to announce Chrisopher Cherry as interim Chief Executive Officer effective January 13, 2025. Mr. Cherry currently sits as a director of the Company and will seamlessly assume the role.

The Company expresses appreciation to Chris Heath for his contribution as CEO wishes him the best in his future endeavors.

About MedBright AI Investments Inc.

MedBright AI is a capital allocator focused on investing in diversified industries, including technology, healthcare, and AI. These include both public and private companies. MedBright has a focus on near-term and midterm high-quality opportunities with strong return potentials while maintaining commitment to governance.

MedBright AI Investments Inc.

Mr. Chrisopher Cherry, Chief Executive Officer

Email: investors@medbright.ai

Phone: (604) 602-0001

www.medbright.ai